ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Merus NV

Merus NV (2GH)

41.40
0.00
( 0.00% )
Updated: 12:08:06
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
41.40
Bid
42.00
Ask
42.60
Volume
0.00
0.00 Day's Range 0.00
21.40 52 Week Range 58.50
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-4.1666666666743.2474319244.19451697DE
4-8.6-17.25051.540.411744.74603537DE
12-3.8-8.4070796460245.251.540.412747.17167127DE
26-6.8-14.107883817448.257.540.415948.57608533DE
5218.4802358.521.39999917344.34418355DE
15617.673.949579831923.858.51916742.00023485DE
26017.673.949579831923.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.0538 €
(50.28%)
1.83M
A6NAsana Inc
21.00 €
(43.84%)
14.41k
NL8Genesis Ai Corp
0.0214 €
(40.79%)
8.33k
XV2PlasCred Circular Innovations Inc
0.0485 €
(40.58%)
206.1k
RQ0DWave Quantum Inc
4.621 €
(29.51%)
791.4k
AXIAtos SE
0.003 €
(-98.48%)
1.37B
M0YNMynaric AG
1.53 €
(-70.12%)
144.89k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.003 €
(-98.48%)
1.37B
D7GNel ASA
0.2639 €
(-1.16%)
3.79M
TUI1Tui AG
8.436 €
(1.54%)
2.04M
TE9Teco 2030 ASA
0.0538 €
(50.28%)
1.83M
LK1Lake Resources
0.0312 €
(0.32%)
1.49M

Discussion

View Full Feed
Doubledown75 Doubledown75 5 minutes ago
Now why would CME introduce a 1 oz contract to satisfy retail demand? It discourages people from buying physical from Costco;)
If btc is golds competitor, why is it considered digital gold? I think COMEX and lbma are screwed now, but hey that's just my take.

CME
antihama antihama 5 minutes ago
No, but I would think that parsing thru the MAA PR gives clues to the additional data such as proteomics we didn’t expect would be in the MAA. Just the meta data backing up the lab analysis, Pathology reports, Expanded Access Protocol and the pseudo group that was separated out would add… a 100,000
NWBO
StockRocket StockRocket 5 minutes ago
GMZP .0005 put this on on the radar...tick tock. https://x.com/StockRocket1/status/1864785514458472856
GMZP
bwmgftw bwmgftw 5 minutes ago
TheWhigs is bullish. We are finally going higher! I might top off my long here if I can rotate profits
into .0001.
PSRU
vlispxpert vlispxpert 5 minutes ago
Looking at it now...thanks
underpar71 underpar71 5 minutes ago
It's funny to people with a sense of humor. Comedy is meant to be that way. But hate speech? That's become a very broad term for those looking to censor.
NWBO
work-n-hard work-n-hard 5 minutes ago
Sure, Not in the fact that they are going to produce any revenue by suing anyone, but faith in what happens after they go on a dumping spree, due to a lack of revenue.
TSOI
GrandAdmiralThrawn GrandAdmiralThrawn 5 minutes ago
To be honest we are down just by a little bit, I’m okay with this. It’s not a bad drop. If it drops below where I bought I’ll buy more, however it looks as though it wants to stay above .0021, so I’m not worried
HMBL
carvajal carvajal 6 minutes ago
SMX is currently up 96.94%
SMX
getmoreshares getmoreshares 6 minutes ago
19m trade just went thru
CGAC
TURCH TURCH 6 minutes ago
Market Cap basically pricing in EM IMO

Wheres Dung with his ???????????????????????????????????????'s lol

The good food has expired


Regards
ASKH
MakinBank MakinBank 6 minutes ago
I have not looked at AXP over a year perhaps they changed their news outlet, something I was trying to have them do over a year until I gave up on them.

No, shareholders Are meaningless. They have to keep shareholders at bay once in a while no? "through the trouble of keeping us well
AXP
xelhorn1 xelhorn1 6 minutes ago
Canopy Share Price (US$)

Fixed Share (ACRHF) Exchange Ratio

US$5.00 and below ˜ 0.00000

US$6.00. ˜ 0.00198

US$7.00. ˜ 0.00683

Floating Share (ACRDF) Exchange Ratio

$0.0
ACRDF
ProfitChaser ProfitChaser 7 minutes ago
Looking good. PPS is hovering right up there around the 52wk high. Ready to break out.
KRTL
USVIHI22 USVIHI22 7 minutes ago
go...last breath
ILST
Invest-in-America Invest-in-America 7 minutes ago
ZJK: See ME below, live right now!!! (Doin' a 'Will Smith' on my own stupid FACE!!!)

https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExczRzNTB0a2ZuNmJwc3I4czRobW5hY2RzcW1xbjRzaG1nanNkNTF0ZiZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/irU9BlmqEwZwc/giphy.gif
"Captain JERK , is a much
ZJK
Yo-Yo Yo-Yo 7 minutes ago
What's up V!!! Yep that one is moving nicely!!! Have you looked at ERNA, seems to be near bottom around .27-.30 hope all is well my man!!!
Craig305 Craig305 7 minutes ago
Cannot trust those 10K lots showing on L2. Most often times there are more shares behind the scenes. I saw the 30K dump hit .038 when 10K were showing and it did not move until another order dumped more.
HWNI
Golf4Food Golf4Food 7 minutes ago
lolzz
fredscott36 fredscott36 8 minutes ago
....in the high-level legal world, a party has to be in receipt of THE MONEY, if applicable......before adjusting a legal position...............

....FDIC ain't gonna terminate a RECEIVER, until the recoveries/collections are complete...............?????......................
lovethatgreen lovethatgreen 8 minutes ago
Buddy are you about done cluttering up the board responding to the clowns that stop by looking for attention ?
MONI
Invest-in-America Invest-in-America 8 minutes ago
ZJK: See ME below, live right now!!! (Doin' a 'Will Smith' on my own stupid FACE!!!)

https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExczRzNTB0a2ZuNmJwc3I4czRobW5hY2RzcW1xbjRzaG1nanNkNTF0ZiZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/irU9BlmqEwZwc/giphy.gif
"Captain JERK , is a much
ZJK
snow snow 8 minutes ago
Diamonhands Yes I know what it means but I don't think that is what happened. People who trust everything that comes from management in this company are pretty slow in their thinking the way I see it.
SPZI

Your Recent History

Delayed Upgrade Clock